Balance Sheet
Cash Flow Statement
AmortizationChange in TaxesNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Cash from Operations (2021 - 2025)

Historic Cash from Operations for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to -$18.2 million.

  • ProQR Therapeutics' Cash from Operations fell 52019.31% to -$18.2 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$72.5 million, marking a year-over-year decrease of 13105.72%. This contributed to the annual value of -$42.3 million for FY2024, which is 28142.48% down from last year.
  • As of Q4 2022, ProQR Therapeutics' Cash from Operations stood at -$18.2 million, which was down 52019.31% from -$15.5 million recorded in Q3 2022.
  • Over the past 5 years, ProQR Therapeutics' Cash from Operations peaked at $4.3 million during Q4 2021, and registered a low of -$23.0 million during Q1 2022.